Similar Articles
191 Prevalence of Helicobacter pylori infection in China from 2014-2023: A systematic review and meta-analysis
192 Present and prospect of transarterial chemoembolization combined with tyrosine kinase inhibitor and PD-1 inhibitor for unresectable hepatocellular carcinoma
193 Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer patients undergoing neoadjuvant chemotherapy: A systematic review and meta-analysis
194 Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report
195 From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies
196 MicroRNA-206 as a promising epigenetic approach to modulate tumor-associated macrophages in hepatocellular carcinoma
197 Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma
198 Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients
199 Single incision laparoscopic surgery for hepatocellular carcinoma
200 Urgent need for prognostic markers for hepatocellular carcinoma in the light of genomic instability and non-coding RNA signatures
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA